title: Alfentanil decreases myoclonus caused by etomidate.
authors.affiliation: University of Texas Health Science Center, Houston, USA. skhalil@anes1.med.uth.tmc.edu
authors.forename: S N
authors.initials: SN
authors.lastname: Khalil
authors.forename: K S
authors.initials: KS
authors.lastname: Lawson
authors.forename: C L
authors.initials: CL
authors.lastname: Hanis
authors.forename: N A
authors.initials: NA
authors.lastname: Lemak
authors.forename: R S
authors.initials: RS
authors.lastname: Ruiz
mesh_terms: D000328:Adult; D000368:Aged; D015760:Alfentanil / Q000627:therapeutic use*; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D002387:Cataract Extraction; D004311:Double-Blind Method; D005045:Etomidate / Q000009:adverse effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009207:Myoclonus / Q000503:physiopathology / Q000517:prevention & control*; D009294:Narcotics / Q000627:therapeutic use*; D010919:Placebos
chemical_list: D018686:Anesthetics, Intravenous; D009294:Narcotics; D010919:Placebos; D015760:Alfentanil; D005045:Etomidate